Comparison of nicorandil and atenolol in stable angina pectoris
References (18)
- et al.
Effects of nicorandil on exercise tolerance in patients with stable effort angina: a double blind study
Am Heart J
(1986) - et al.
Comparison of bevantolol and atenolol in chronic stable angina
Am J Cardiol
(1988) - et al.
Verapamil in chronic stable angina: a controlled study with computerized treadmill exercise
Lancet
(1980) - et al.
Acute and sustained effects of isosorbide 5 mononitrate in stable angina pectoris
Am J Cardiol
(1986) - et al.
Pharmacological profile of a new coronary vasodilator drug, 2-nicotinamidoethyl nitrate (SG 75)
Clin Exp Pharmacol Physiol
(1979) - et al.
Cardiovascular effects of a new coronary vasodilator n-2-hydroxyethyl nicotinamide nitrate SG 75: comparison with nitroglycerin and diltiazem
J Cardiovasc Pharmacol
(1981) - et al.
Evaluation of anti anginal drugs by coronary arteriography
Chiryo
(1978) - et al.
Effects of 2-nicotinamidoethyl nitrate (SG 75) on membrane potentials of canine purkinje fibers
Jpn J Pharmacol
(1981) - Thormann J, Schlepper M, Kramer W, Gottwik M, Kindler M. Effectiveness of nicorandil (SG 75), a new long acting drug...
Cited by (36)
Refractory Angina
2018, Chronic Coronary Artery Disease: A Companion to Braunwald's Heart DiseaseRefractory Angina
2017, Chronic Coronary Artery Disease: A Companion to Braunwald's Heart DiseaseManagement standards for stable coronary artery disease in India
2016, Indian Heart JournalCitation Excerpt :Nicorandil functions via activating ATP–sensitive potassium channels and promoting systemic venous and coronary vasodilatation, eventually it causes a rise in coronary blood flow, a decrease in after-load, preload and oxidative injury.105 The efficacy of nicorandil in patients with stable angina has been compared to placebo, alone or in combination with standard anti-anginal medications in randomised trials, including the Impact Of Nicorandil in Angina (IONA) randomised study,106 the Study of Women's health Across the Nation (SWAN) group study,107 and some Asian studies.108–110 A meta-analysis evaluating the short-term efficacy of nicorandil compared with anti-anginal drugs for stable angina found that nicorandil did not show a significant reduction of weekly angina frequency.
Management of Patients With Refractory Angina: Canadian Cardiovascular Society/Canadian Pain Society Joint Guidelines
2012, Canadian Journal of CardiologyCitation Excerpt :The anti-anginal properties of nicorandil have been known for more than 30 years. A series of small RCTs suggested that nicorandil can exert an anti-ischemic effect comparable to conventional doses of β-blockers, oral nitrates, and calcium antagonists in patients with stable effort angina pectoris.151-158 Because of the large individual variations in the rates of anginal attack and exercise duration on treadmill stress test, these studies were underpowered to detect any significant differences between nicorandil and other anti-anginal agents.
Antianginal medications and diagnostic accuracy of myocardial perfusion imaging
2003, Journal of Nuclear CardiologyACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina
1999, Journal of the American College of Cardiology